Subcommittee to Hold Second Hearing on the Public Health Risks of Carcinogens in Consumer Products

Dec 9, 2019
Press Release
Johnson & Johnson Refused Multiple Invitations to Publicly Testify Before the Subcommittee

Washington D.C. (Dec. 9, 2019)—On Tuesday, December 10, 2019, Rep. Raja Krishnamoorthi, the Chairman of the Subcommittee on Economic and Consumer Policy, will hold a hearing assessing scientific methods utilized to detect asbestos in talcum powders, and public health ramifications.

Johnson & Johnson has refused the Subcommittee’s invitations to testify publicly – despite nearly a month’s advance notice and the Subcommittee’s repeated attempts to accommodate the company.

WHERE: 2154 Rayburn House Office Building

WHEN: Tuesday, December 10, 2019

TIME: 1:00 p.m. EST

A livestream of the hearing will be available here.


The hearing will examine health risks related to use of talcum powders containing asbestos, and detection methods that bolster public health.  


  • On October 18, 2019, the Food and Drug Administration (FDA) announced that it had detected asbestos in one lot of Johnson & Johnson’s baby powder and that the company voluntarily recalled the product. FDA warned consumers to discontinue the use of bottles from the tested lot.  
  • FDA’s announcement resulted in Johnson & Johnson recalling nearly 33,000 bottles of baby powder in the United States.  Since the recall, Johnson & Johnson has attempted to impugn the integrity of FDA’s positive test results. 
  • The company claims that “thousands of tests over the past forty years repeatedly confirm that our consumer talc products do not contain asbestos.”  However, internal Johnson & Johnson memos from 1971 reveal the company knew its talc-based baby powder potentially contained asbestos.  The senior staffer who authored the memo recommended Johnson & Johnson “upgrade” its scrutiny of talc safety. 
  • Industry methods for detecting asbestos in talc primarily involve two testing methods: polarized light microscopy (PLM), and the use of an analytical transmission electron microscope (ATEM). Both PLM and ATEM have been criticized for lacking proper sensitivity to detect very low levels of asbestos contamination.  Laboratories with which industry and FDA contract to do asbestos detection in talc testing almost entirely rely upon these methods. 
  • Since the 1960s, scientists have identified a link between ovarian cancer and the use of powders containing talc.  The International Agency for Research on Cancer (IARC) reports that talc-containing asbestos is carcinogenic to humans and can cause mesothelioma. IARC also concludes that use of talc-containing baby powder in the perineal (genital) region could be carcinogenic to humans. 
  • The FDA, the World Health Organization, and numerous other public health organizations do not recognize any safe or acceptable amount of asbestos in talc.


Panel One

Alex Gorsky
Chief Executive Officer
Johnson & Johnson

Panel Two

Dr. William Longo
Materials Analytical Services, LLC

Dr. Professor Rod Metcalf
University of Nevada-Las Vegas

Dr. Jacqueline Moline
Feinstein Institutes for Medical Research at Northwell Health

David Etheridge


116th Congress